@article{3c7a13127d46441b9de39162dbc96b63,
title = "Perspective for prophylaxis and treatment of cervical cancer: An immunological approach",
abstract = "As the second most common cause of cancer-related death in women, human papilloma virus (HPV) vaccines have been a major step in decreasing the morbidity and mortality associated with cervical cancer. An estimated 490,000 women are diagnosed with cervical cancer each year. Increasing knowledge of the HPV role in the etiology of cervical cancer has led to the development and introduction of HPV-based vaccines for active immunotherapy of cervical cancer. Immunotherapies directed at preventing HPV-persistent infections. These vaccines are already accessible for prophylaxis and in the near future, they will be available for the treatment of preexisting HPV-related neoplastic lesions.",
keywords = "Cancer vaccines, Gynecologic oncology, HPV, Immunotherapy, Tumor prevention",
author = "Marjorie Jenkins and Maurizio Chiriva-Internati and Leonardo Mirandola and Catherine Tonroy and Tedjarati, {Sean S.} and Nicole Davis and Nicholas D'Cunha and Lukman Tijani and Fred Hardwick and Diane Nguyen and Kast, {W. Martin} and Everardo Cobos",
note = "Funding Information: Accepted 30 October 2011. Marjorie Jenkins and Maurizio Chiriva-Internati contributed equally to this article. W. Martin Kast holds the Walter A. Richter Cancer Research Chair. We thank Teri Fields for assistance in revising this manuscript. This review is partially based on research that is supported by NIH grants RC2 CA148298-01 and RO1 CA74397-11 (to WMK). This review has been partially supported by the Associate Dean of the Oncology Programs at TTUHSC. The Billy and Ruby Power Endowment for Cancer Research (MCI) and Laura W. Bush Institute for Women{\textquoteright}s Health (MCI) and Mrs. J. Avery “Janie” Rush Endowed Chair of Excellence in Women{\textquoteright}s Health and Oncology (MCI).",
year = "2012",
month = feb,
doi = "10.3109/08830185.2011.637254",
language = "English (US)",
volume = "31",
pages = "3--21",
journal = "International Reviews of Immunology",
issn = "0883-0185",
publisher = "Informa Healthcare",
number = "1",
}